Remove Anatomy Remove Aortic Remove TAVR
article thumbnail

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

DAIC

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. Circulation.

TAVR 111
article thumbnail

Bicuspid Anatomy: Wrench Thrown in TAVR for Younger, Low-Risk Patients?

Med Page Today

(MedPage Today) -- PARIS -- Patients with questionable suitability for transcatheter aortic valve replacement (TAVR) in fact fared worse in the short term after the catheter-based procedure than after surgery, the NOTION-2 randomized trial showed.

TAVR 52
article thumbnail

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

DAIC

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves.

TAVR 111
article thumbnail

What Is TAVR? A Closer Look at Transcatheter Aortic Valve Replacement

AMS Cardiology

If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. If you’re wondering “ What is TAVR ?” Understanding Aortic Stenosis The aortic valve regulates blood flow from your heart’s main pumping chamber to the rest of your body. Who Is a Candidate for TAVR?

article thumbnail

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

DAIC

The SMART trial is the first randomized head-to-head comparison of the two most widely used TAVR devices—the supra-annular self-expanding Evolut PRO/PRO+/FX and the balloon-expandable SAPIEN 3/3 Ultra. The trial enrolled 716 patients who underwent TAVR at 83 international sites in North America, Europe and the Middle East.

TAVR 59
article thumbnail

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Circulation: Cardiovascular Interventions

BACKGROUND:Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. Virtual Evolut and Sapien-3 valves were sized using CT-based diameters. Two initial Evolut implant depths were analyzed, 3 and 5 mm.

TAVR 40
article thumbnail

Association of Bovine Arch Anatomy With Incident Stroke After Transcatheter Aortic Valve Replacement

Journal of the American Heart Association

BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). This study aimed to identify the aortic anatomic correlates in patients after TAVR stroke.Methods and ResultsThis is a single‐center, retrospective study of patients who underwent TAVR at the Mayo Clinic between 2012 and 2022.